Johns Hopkins and Salk Co-lead $15 Million Initiative to Unravel Bipolar Disorder and Schizophrenia August 31, 2016October 19, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmail Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Cardiomyocytes iCell Cardiomyocytes2 iCell Cardiac Progenitor Cells iCell Neurons iCell Astrocytes iCell DopaNeurons iCell GlutaNeurons iCell Hepatocytes 2.0 iCell Hepatoblasts iCell Skeletal Myoblasts iCell Endothelial Cells iCell Hematopoietic Progenitor Cells iCell Macrophages iCell Mesenchymal Stem Cells MyCell Products Disease & Diversity Products • CIRM Disease Models MyCell Services Applications All Applications Discovery Disease Modeling Regenerative Medicine Toxicity Resources Support Knowledge Base Technical Support Customer Support Frequently Asked Questions User Documentation iCell Institute iCertification Training Videos CDI Hosted Meetings Grant Program CDI Customer Stories Documents Product Literature Certificate Lookup Peer-Reviewed Publications Poster Presentations Podium Presentations News & Events News CDI in the News Press Releases Product News Awards & Accolades eNewsletters Events Promotions Conferences Past Webinars Upcoming Webinars CDI Hosted Meetings Subscribe About Us A Message from Our CEO Vision, Mission & Values Management Team Careers Contact Us News & Events News CDI in the News Press Releases Product News Awards & Accolades eNewsletters Events Promotions Conferences Past Webinars Upcoming Webinars CDI Hosted Meetings Subscribe Related News: Imaging the Cytoskeleton to Understand SchizophreniaIllumina to Donate US $60 Million in Sequencing…Roche’s ENSPRYNG approved by European Commission as…Roche to present new data on OCREVUS in multiple…Roche to present new OCREVUS (ocrelizumab) data in…New four-year data show Roche's ENSPRYNG…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
